ReNeuron Receives Notice Of Allowance From US Patent Office For Neural Stem Cell Transplantation Patent Application.

ReNeuron Group plc (LSE: RENE.L) today announced that it has received a Notice of Allowance from the US Patent and Trademark Office concerning a key patent application for methods of transplantation of neural stem cells.

MORE ON THIS TOPIC